Schwann cells require the formation of an organized basal lamina in order to properly ensheath and myelinate axons. Laminins are a group of heterotrimeric extracellular proteins and are critical components within the basal lamina responsible for these processes in peripheral nervous system (PNS). Laminin gamma1 is a component of most laminin isoforms identified to date and is a subunit of laminin-2 (alpha2 beta1 gamma1), the major laminin isoform present in Schwann cell basal lamina. To investigate the function of laminin gamma1 in the PNS, we generated mice homozygous for a laminin gamma1 gene that has a critical exon flanked by IoxP recombination sites (fLAM gamma1) that also carry a Cre recombinase transgene under the control of a Schwann cell-specific promoter, the myelin protein zero (P0) promoter. These mice have disruption of the laminin gamma1 gene in their peripheral nerves, resulting in a severe defect in myelination. The objectives of this proposal are to take advantage of these mice with Schwann cell-specific disruption of laminin gamma1 gene to investigate the role of laminin in the development, myelination, and maintenance of the PNS. To accomplish this goal, we propose three specific aims. First, we will investigate the mechanisms of action of laminin gamma1 in signaling pathways involved in Schwann cell proliferation and apoptosis. Second, we will investigate the mechanisms of action of laminin gamma1 in radial sorting and myelination of PNS. Third, we will investigate the role of laminin gamma1 in the maintenance of peripheral nerves. These experiments will allow us to understand the mechanisms of Schwann cell-basal lamina interactions and may suggest possible new approaches to the therapy of peripheral neuropathies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS038472-09
Application #
7259348
Study Section
Neurodegeneration and Biology of Glia Study Section (NDBG)
Program Officer
Kleitman, Naomi
Project Start
1999-04-23
Project End
2009-05-31
Budget Start
2007-06-01
Budget End
2009-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$438,263
Indirect Cost
Name
Rockefeller University
Department
Biology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
McKee, Karen K; Yang, Dong-Hua; Patel, Rajesh et al. (2012) Schwann cell myelination requires integration of laminin activities. J Cell Sci 125:4609-19
Carlson, Karen B; Singh, Prabhjot; Feaster, Moses M et al. (2011) Mesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice deficient in Schwann cell-derived laminin. Glia 59:267-77
Skrzypiec, Anna E; Maiya, Rajani; Chen, Zulin et al. (2009) Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration. Biol Psychiatry 66:785-94
Chen, Zu-Lin; Haegeli, VĂ©ronique; Yu, Huaxu et al. (2009) Cortical deficiency of laminin gamma1 impairs the AKT/GSK-3beta signaling pathway and leads to defects in neurite outgrowth and neuronal migration. Dev Biol 327:158-68
Dhadialla, Prabhjot S; Ohiorhenuan, Ifije E; Cohen, Andrew et al. (2009) Maximum-entropy network analysis reveals a role for tumor necrosis factor in peripheral nerve development and function. Proc Natl Acad Sci U S A 106:12494-9
Yu, Wei-Ming; Yu, Huaxu; Chen, Zu-Lin et al. (2009) Disruption of laminin in the peripheral nervous system impedes nonmyelinating Schwann cell development and impairs nociceptive sensory function. Glia 57:850-9
Yu, Wei-Ming; Chen, Zu-Lin; North, Alison J et al. (2009) Laminin is required for Schwann cell morphogenesis. J Cell Sci 122:929-36
Chernousov, Michael A; Yu, Wei-Ming; Chen, Zu-Lin et al. (2008) Regulation of Schwann cell function by the extracellular matrix. Glia 56:1498-507
Yu, Wei-Ming; Yu, Huaxu; Chen, Zu-Lin (2007) Laminins in peripheral nerve development and muscular dystrophy. Mol Neurobiol 35:288-97
Schaefer, Ulrich; Vorlova, Sandra; Machida, Takuji et al. (2007) Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase. J Pharmacol Exp Ther 322:265-73

Showing the most recent 10 out of 24 publications